BioSpace News Archive

Deals

Bruker Announces Quarterly Dividend - Nov. 14, 2019

Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.04 per share on the Company’s common stock.

November 14, 2019
·
1 min read
Business

Inozyme Pharma Expands Medical Leadership Team

Strengthens Inozyme’s Ability to Advance Lead Candidate, INZ-701, into Clinical Trials

November 14, 2019
·
4 min read
Theratechnologies’ CFO to Attend Stifel Healthcare Conference in New York City

Theratechnologies Inc., a commercial-stage biopharmaceutical company, is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend the Stifel Healthcare Conference which will be held in New York City on November 19th, 2019.

November 14, 2019
·
2 min read
Bio NC

BioCryst to Present at Upcoming Investor Conferences

BioCryst Pharmaceuticals, Inc. announced that the company will present at the Jefferies London Healthcare Conference on Thursday, November 21, 2019 at 3:40 a.m. ET and the Piper Jaffray 31st Annual Healthcare Conference in New York on Tuesday, December 3, 2019 at 4:30 p.m. ET.

November 14, 2019
·
1 min read
FDA

FDA approves therapy to treat patients with relapsed and refractory mantle cell lymphoma supported by clinical trial results showing high response rate of tumor shrinkage

The U.S. Food and Drug Administration granted accelerated approval to Brukinsa capsules for the treatment of adult patients with mantle cell lymphoma who have received at least one prior therapy.

November 14, 2019
·
4 min read
Business

aTyr Pharma Announces Third Quarter 2019 Results and Provides Corporate Update

Interim safety results from Phase 1b/2a proof-of-concept trial of ATYR1923 in pulmonary sarcoidosis patients due in December 2019

November 14, 2019
·
7 min read
Deals

Sienna Biopharmaceuticals Announces Court Approval of Chapter 11 Bidding Procedures Bids due on December 2, 2019 by 5:00 p.m. Eastern Time

Sienna Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, today announced that, on November 13, 2019, the United States Bankruptcy Court for the District of Delaware entered an order approving Sienna’s proposed bidding procedures and Chapter 11 sale process timeline.

November 14, 2019
·
3 min read
Business

BrainsWay to Report Third Quarter 2019 Financial Results on November 25, 2019

BrainsWay Ltd., a global leader in the advanced non-invasive treatment of brain disorders, announced that it will report its third quarter 2019 financial results before the opening of the U.S. financial markets on Monday, November 25, 2019.

November 14, 2019
·
4 min read
Business

Osmotica Pharmaceuticals plc Reports Third Quarter 2019 Results

Submitted NDA for RVL-1201 (oxymetazoline hydrochloride ophthalmic solution, 0.1%) for acquired blepharoptosis, or droopy eyelid, to FDA

November 14, 2019
·
11 min read
Business

Zyla Life Sciences Reports Third Quarter 2019 Financial Results

Positive net cash flow of $6.5 million for the quarter ended September 30, 2019

November 14, 2019
·
10 min read